ORB-0001

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameORB-0001
Drug Alias NameBcr-Abl and Scr kinases inhibitor (OriBase)ORB-0001OB-0001
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsBcr-Abl tyrosine kinase inhibitorsTyrosine-protein kinase SRC inhibitors
TargetsBcr-Abl tyrosine kinaseTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOriBase Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOriBase Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A